Absorption |
Blood-Brain Barrier | BBB+ | 0.9681 |
Human Intestinal Absorption | HIA+ | 0.8011 |
Caco-2 Permeability | Caco2+ | 0.7009 |
P-glycoprotein Substrate | Non-substrate | 0.8261 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9759 |
Non-inhibitor | 0.9944 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9328 |
Distribution |
Subcellular localization | Mitochondria | 0.8941 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8270 |
CYP450 2D6 Substrate | Non-substrate | 0.9316 |
CYP450 3A4 Substrate | Non-substrate | 0.8009 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8135 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9482 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9170 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9224 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9769 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9590 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9689 |
Non-inhibitor | 0.9884 |
AMES Toxicity | Non AMES toxic | 0.9676 |
Carcinogens | Non-carcinogens | 0.7538 |
Fish Toxicity | High FHMT | 0.9430 |
Tetrahymena Pyriformis Toxicity | Low TPT | 0.5520 |
Honey Bee Toxicity | High HBT | 0.5760 |
Biodegradation | Ready biodegradable | 0.9738 |
Acute Oral Toxicity | IV | 0.6860 |
Carcinogenicity (Three-class) | Non-required | 0.7570 |